Literature DB >> 818021

Evaluation of adenosine deaminase and other purine salvage pathway enzymes in horses with combined immunodeficiency.

T C McGuire, B Pollara, J J Moore, M J Poppie.   

Abstract

Foals with combined immunodeficiency had normal levels of purine salvage pathway enzymes, including adenosine deaminase, nucleoside phosphorylase, and xanthine oxidase.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 818021      PMCID： PMC420706          DOI： 10.1128/iai.13.3.995-997.1976

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  12 in total

1.  A STUDY OF THE TISSUE DISTRIBUTION OF ADENOSINE DEAMINASE IN SIX MAMMAL SPECIES.

Authors:  T G BRADY; C I O'DONOVAN
Journal:  Comp Biochem Physiol       Date:  1965-01

2.  Workshop on severe combined immunological deficiency disease and adenosine deaminase deficiency. Albany, New York, on October 1, 1973.

Authors:  R J Pickering; B Pollara; H J Meuwissen
Journal:  Clin Immunol Immunopathol       Date:  1974-11

3.  Combined (B- and T-lymphocyte) immunodeficiency: a fatal genetic disease in Arabian foals.

Authors:  T C McGuire; M J Poppie; K L Banks
Journal:  J Am Vet Med Assoc       Date:  1974-01-01       Impact factor: 1.936

4.  Letter: Combined-immunodeficiency disease with normal erythrocyte A.D.A.

Authors:  W R Bartholomew; T T Provost
Journal:  Lancet       Date:  1974-04       Impact factor: 79.321

5.  Letter: Autosomal assignment of the gene for the form of adenosine deaminase which is deficient in patients with combined immunodeficiency syndrome.

Authors:  R P Creagan; J A Tischfield; E A Nichols; F H Ruddle
Journal:  Lancet       Date:  1973-12-22       Impact factor: 79.321

6.  Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity.

Authors:  E R Giblett; J E Anderson; F Cohen; B Pollara; H J Meuwissen
Journal:  Lancet       Date:  1972-11-18       Impact factor: 79.321

7.  Combined immunodeficiency in horses: characterization of the lymphocyte defect.

Authors:  T C McGuire; K L Banks; M J Poppie
Journal:  Clin Immunol Immunopathol       Date:  1975-03

8.  Hypogammaglobulinemia and thymic hypoplasia in horses: a primary combined immunodeficiency disorder.

Authors:  T C McGuire; M J Poppie
Journal:  Infect Immun       Date:  1973-08       Impact factor: 3.441

9.  Detection of the carrier state in combined immunodeficiency disease associated with adenosine deaminase deficiency.

Authors:  C R Scott; S H Chen; E R Giblett
Journal:  J Clin Invest       Date:  1974-04       Impact factor: 14.808

10.  Estimation of the molecular weights of proteins by Sephadex gel-filtration.

Authors:  P Andrews
Journal:  Biochem J       Date:  1964-05       Impact factor: 3.766
View more
  5 in total

1.  Adenosine deaminase activity in thymus and other human tissues.

Authors:  A Adams; R A Harkness
Journal:  Clin Exp Immunol       Date:  1976-12       Impact factor: 4.330

2.  Alterations of the thymus and other lymphoid tissue in young horses with combined immunodeficiency.

Authors:  T C McGuire; K L Banks; W C Davis
Journal:  Am J Pathol       Date:  1976-07       Impact factor: 4.307

3.  Azathioprine and 6-mercaptopurine (6-MP) suppress the human mixed lymphocyte reaction (MLR) by different mechanisms.

Authors:  S A Al-Safi; J L Maddocks
Journal:  Br J Clin Pharmacol       Date:  1984-04       Impact factor: 4.335

4.  In vitro of adenosine on lymphocytes and erythrocytes from horses with combined immunodeficiency.

Authors:  N S Magnuson; L E Perryman
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

5.  Reference values for amino acids and acylcarnitines in peripheral blood in Quarter horses and American Miniature horses.

Authors:  Irám Pablo Rodríguez-Sánchez; Víctor Manuel Treviño-Alvarado; María del Rosario Torres-Sepúlveda; Liliana Aracely López-Saldaña; Gustavo Ponce-García; Graciela Areli López-Uriarte; María del Consuelo Ruiz-Herrera; Diana Elisa Zamora-Ávila; Jesús Zacarías Villarreal-Pérez; Guillermo Dávalos-Aranda; Laura Elia Martínez-de-Villarreal
Journal:  Acta Vet Scand       Date:  2015-09-29       Impact factor: 1.695
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.